KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Payables (2016 - 2025)

Cvs Health's Payables history spans 17 years, with the latest figure at $17.6 billion for Q4 2025.

  • For the quarter ending Q4 2025, Payables fell 2.05% year-over-year to $17.6 billion, compared with a TTM value of $17.6 billion through Dec 2025, down 2.05%, and an annual FY2025 reading of $17.6 billion, down 2.05% over the prior year.
  • Payables for Q4 2025 was $17.6 billion at Cvs Health, down from $19.0 billion in the prior quarter.
  • The five-year high for Payables was $20.3 billion in Q2 2025, with the low at $11.1 billion in Q2 2021.
  • Average Payables over 5 years is $15.0 billion, with a median of $14.6 billion recorded in 2022.
  • Biggest YoY gain for Payables was 40.8% in 2025; the steepest drop was 2.05% in 2025.
  • Tracing CVS's Payables over 5 years: stood at $12.5 billion in 2021, then increased by 18.29% to $14.8 billion in 2022, then grew by 1.75% to $15.1 billion in 2023, then grew by 19.3% to $18.0 billion in 2024, then fell by 2.05% to $17.6 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Payables are $17.6 billion (Q4 2025), $19.0 billion (Q3 2025), and $20.3 billion (Q2 2025).